Robert Erwin

Robert Erwin serves as the Chief Executive Officer of Oryn Therapeutics, Inc. since 2020, leading a clinical-stage company dedicated to innovative drug development through Orynotides for treating inflammatory, infectious, and auto-immune diseases. Previously, Robert held the position of President at the Marti Nelson Cancer Foundation, a patient advocacy organization, from 1994 to 2022. Additionally, Robert was the Chairman of Novici Biotech LLC from 2007 to 2021 and served as President of iBio, Inc. from 2007 to 2020, with the latter focusing on plant-based protein manufacturing for vaccines. Robert's earlier roles include Managing Director of Bio-Strategic Directors LLC and Chairman positions at Icon Genetics AG and Large Scale Biology Corporation. Robert earned a Master of Science in Genetics from Louisiana State University between 1972 and 1978.